Valeant Shares Plunge After C.E.O. Is Subpoenaed by Congress
TRENTON, N.J. — Shares of beleaguered Canadian drugmaker Valeant Pharmaceuticals plunged again Monday after its chief executive was subpoenaed by a congressional committee.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.